Albert II of Monaco
“I hope you will join me in supporting EORTC in its unique work to improve cancer care for us all. Thank you.”
Members of the General Assembly
Dr. Jean de Gunzburg
HRH Prince Guillaume de Luxembourg
HE Evelyne Genta
Prof. Gordon McVie
Prof. Roger Stupp
Creation of the EORTC Foundation. HRH Prince Philip, the Duke of Edinburgh becomes the first Honorary President.
EORTC Fellowship Program is launched. Fellows from around the world spend 1 to 3 years at EORTC headquarters, engaged in work related to EORTC research projects or programs and becoming familiar with practical aspects of clinical research including clinical trial methodology, regulatory affairs, data management, statistics, medical monitoring and the reporting of results.
H.M. Queen Sofia of Spain becomes Honorary President.
H.M. Queen Silvia of Sweden becomes Honorary President.
H.R.H Princess Astrid of Belgium becomes Honorary President.
Walgreens Boots Alliance (WBA) forms a partnership with ECRF to support the creation of the SPECTA Biobank and research platform. WBA committed €5m over five years for this pioneering project by fundraising through its companies in Europe.
Leukemia in the elderly: a project sponsored by The ‘HRH Prince Alwaleed Foundation’. After completion of the first phase, the research project was presented at the American Society of Hematology’s prestigious conference in New Orleans, (USA).
ECRF receives annual core support of €1.3 million from various European national cancer charities and the Hong Kong Cancer Fund. Launch of Sallie Snowman Survivorship Initiative, studying key clinical questions concerning long term cognitive effects in patients after a cancer treatment. This initiative also addresses cancer socio-economical and psychological issues.
H.S.H Prince Albert II of Monaco becomes Honorary President • Sir Ronald Grierson, EORTC Foundation founding Chairman, retires • Sir Christopher Mallaby retires to become Honorary Vice President • Comte Diego du Monceau de Bergendal becomes Chairman • Professor John Smyth becomes ECRF Vice Chairman • Transatlantic Rare Cancers Initiative begins